Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherCLINICAL INVESTIGATIONS

Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin’s Lymphomas

Pieternella J. Lugtenburg, Bob Löwenberg, Roelf Valkema, Hong-Yoe Oei, Steven W. Lamberts, Marinus J. Eijkemans, Wim L. van Putten and Eric P. Krenning
Journal of Nuclear Medicine February 2001, 42 (2) 222-229;
Pieternella J. Lugtenburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bob Löwenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roelf Valkema
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong-Yoe Oei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven W. Lamberts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marinus J. Eijkemans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim L. van Putten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric P. Krenning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Visualization of submandibular lymph node in 42-y-old woman with stage IA NHL of low-grade malignancy by SS-R scintigraphy. Right lateral image of head and neck shows grade 2 pathologic uptake (arrow) within submandibular lesion. Normal uptake of radioactivity is seen in thyroid. On physical examination, lymph node of 3 cm in diameter was palpated.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    SS-R scintigraphy in 36-y-old man with low-grade NHL shows multiple enlarged lymph nodes of 2–3 cm in diameter in right inguinal and iliac regions. Pathologic lymph nodes are clearly seen (grade 2 uptake, arrow). Normal accumulation of radioactivity is seen in bladder and kidneys.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    SS-R scintigraphy in 52-y-old woman with low-grade NHL shows pathologic uptake in abdominal region between kidneys (arrow). Normal uptake of radioactivity is seen in enlarged spleen. Normal uptake is also seen in liver and kidneys. CT scan of abdomen showed enlarged mesenteric lymph nodes.

Tables

  • Figures
    • View popup
    TABLE 1.

    Clinical Characteristics of 50 Patients with Low-Grade NHL

    CharacteristicNo. of patients (%)*
    Sex
     Male30  (60)
     Female20  (40)
    Ann Arbor clinical stage†
     I25  (50)
     II5  (10)
     III7  (14)
     IV13  (26)
    Histologic subtype (Working Formulation)
     A: Small lymphocytic7  (14)
     B: Follicular, predominantly small cleaved cell2  (4)
     C: Follicular, mixed small cleaved and large cell30  (60)
     MALT9  (18)
     Unclassifiable low grade2  (4)
    • ↵* Age range, 28–76 y; mean age, 51 y.

    • ↵† Based on results of standard staging procedures.

    • View popup
    TABLE 2.

    Anatomic Distribution of 162 Malignant Lesions in 50 Patients with Low-Grade NHL

    Localization of malignant lesion% of patients
    Neck LN56
    Para-aortic LN34
    Mesenteric LN22
    Inguinal LN20
    Mediastinal LN18
    Axillary LN18
    Iliac LN12
    Spleen10
    Stomach10
    Orbit/eye10
    Lung hilar LN4
    Waldeyer’s ring4
    Intestine4
    Skin4
    Central nervous system2
    Urinary bladder2
    Pleura2
    Parotid gland2
    Mouth2
    • * Diagnosed on basis of conventional staging procedures and SS-R scintigraphy.

    • LN = lymph node.

    • View popup
    TABLE 3.

    Comparison of Results of SS-R Scintigraphy with Those of Conventional Staging in 50 Patients with Low-Grade NHL

    ResultNo. of patients (%)
    SS-R scan detects new lesions10  (20)
    SS-R scan misses lesions19  (38)
    SS-R scan both detects new lesions and misses lesions in same patient3  (6)
    Agreement between SS-R scan and conventional staging procedures18  (36)
    • View popup
    TABLE 4.

    Clinical Stage Based on Conventional Staging Procedures Complemented with SS-R Scintigraphy Compared with Clinical Stage Based on Conventional Staging Only

    Stage based on conventional staging complemented with SS-R scintigraphyStage based on conventional staging only*
    IIIIIIIVTotal
    I1510016
    II54009
    III4†07011
    IV1†001314
    Total25571350
    • ↵* Conventional staging procedures excluding bone marrow pathology.

    • ↵† Change in clinical stage with potential consequences for treatment choice.

    • View popup
    TABLE 5.

    Sensitivity of Various Diagnostic Approaches for Detection of Low-Grade NHL Lesions in Different Lymph Node Regions and Extranodal Sites

    Localization of malignant lesionNo. of malignant lesionsPhysical examination (%)Chest radiograph (%)CT scan (%)LAG (%)Sonography (%)SS-R scan (%)
    Cervical LN*389670  (10)66
    Supraclavicular LN179063  (8)59
    Axillary LN169486  (14)63
    Mediastinal LN925  (8)100  (8)78
    Orbit/eye66740  (5)33
    Lung-hilar LN3010067
    Paraaortic LN1782100  (2)43  (7)35
    Mesenteric LN1110067  (6)36
    Inguinal LN136985  (13)54
    Iliac LN109030
    Stomach/intestine81338
    Spleen5100100100  (2)100
    • ↵* Indicates occipital, submandibular, and cervical lymph nodes.

    • LAG = bipedal lymphangiogram; LN = lymph node.

    • Numbers in parentheses indicate frequency at which the test was performed and are given only if different from number of malignant lesions.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 2
February 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin’s Lymphomas
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin’s Lymphomas
Pieternella J. Lugtenburg, Bob Löwenberg, Roelf Valkema, Hong-Yoe Oei, Steven W. Lamberts, Marinus J. Eijkemans, Wim L. van Putten, Eric P. Krenning
Journal of Nuclear Medicine Feb 2001, 42 (2) 222-229;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin’s Lymphomas
Pieternella J. Lugtenburg, Bob Löwenberg, Roelf Valkema, Hong-Yoe Oei, Steven W. Lamberts, Marinus J. Eijkemans, Wim L. van Putten, Eric P. Krenning
Journal of Nuclear Medicine Feb 2001, 42 (2) 222-229;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The role of somatostatin and dopamine D2 receptors in endocrine tumors
  • Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
  • Molecular Imaging of bcl-2 Expression in Small Lymphocytic Lymphoma Using 111In-Labeled PNA-Peptide Conjugates
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire